High TLN1 abundance in the BM plasma of patients with a high-risk MDS subtype (MDS-EB) may relate to TLN1-mediated activation of FAK/AKT signaling and anoikis resistance (67). Here, AKT1 is linked to myelodysplastic syndrome.